Recently Added |View All
Join us in person or online for an international comprehensive educational symposium on chronic obstructive pulmonary disease (COPD). This is the seventh consecutive year for this one-day COPD conference. Wednesday, November 16, 2022 from 8:00 AM – 6:00 PM EST
Presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education, this conference is designed as a forum for discussion of advances in technology and treatment of early stage non-small ...
Chronic bronchitis is a clinical diagnosis characterized by chronic cough and phlegm production. It is typically associated with cigarette smoking and puts individuals at risk for respiratory exacerbations, reduces health related quality ...
Friederich Kueppers, MD discusses a study indicating a link between Alpha-One Antitrypsin Deficiency and Aortic Aneurysm.
Pulmonary hypertension encompasses a broad scope of disease states. This program will focus on pulmonary arterial hypertension (PAH) which begins as a vasculopathy within the small pulmonary arteries.
Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients causing pulmonary dysfunction.
This activity is intended for medical professionals who have a clinical interest in the management of pulmonary embolisms as seen by the following medical specialists: Pulmonologists, Hospitalists, Intensivists, Primary Care Providers, ...
Patients with advanced Chronic Obstructive Pulmonary Disease (COPD) are at increased risk of lung cancer, and should be screened with low-dose CT.
In this podcast recorded by the American Association of Bronchology and Interventional Pulmonology, Gerard J. Criner, MD discusses patient selection for Bronchoscopic Lung Volume Reduction.
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality and morbidity worldwide.
A pilot study at Temple suggests that daily use of humidified nasal high-flow (NHF) therapy with an air-oxygen blend as a maintenance therapy could benefit patients discharged from hospital after an acute exacerbation of COPD.
Persistent pulmonary hypertension of the newborn (PPHN, also known as neonatal pulmonary hypertension and persistent fetal circulation syndrome), affects 2% of live births and is a major cause of neonatal mortality.
Gerard J. Criner, MD, FACP, FACCP, outlines the details of the Gala Therapeutics RheSolve Study for treating patients with chronic bronchitis.
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States. Despite optimal pharmacological treatment, many patients with chronic obstructive pulmonary disease remain very disabled.
Pulmonary embolism (PE) is the third most common cardiovascular cause of inpatient hospital death in the United States, and the prevalence of PE risk factors—including surgery, obesity, a sedentary or immobile lifestyle, and advanced age—is ...